THIS WEBSITE IS ON SALE!!This repository of information on pharma regulatory affairs in Latin America could be yours. GET THE READER FLOW YOU NEED TO PROMOTE YOUR PHARMA CONSULTING BUSINESS!! 1,500 VISITORS A MONTH AND GROWING. GET IN TOUCH! email@example.com / firstname.lastname@example.org
- Regulatory Affairs in Emerging Markets
- Fundamentals of Regulatory Affairs
- ANMAT: the Argentinean Health Authority
- Drug registration in Argentina
- Registration of biological drug products in Argentina
- First batch verification
- Drug product certificate renewal in Argentina
- Orphan drug regulation
- GMP inspections: regulatory aspects
- Central America
- Get in touch!
Category Archives: Brazil
Anvisa Approves Track and Trace System
Anvisa Approves Track and Trace System.
Posted in Brazil Leave a comment
Brazil makes proposed outsourcing regulations available for comment
Brazil makes proposed outsourcing regulations available for comment.
Brazil: ANVISA bans Lorcaserin (Belviq)
Today ANVISA, the Brazilian health authority with competence on the control of pharmaceutical products and APIs, banned the manufacturing, import, commercialization, manipulation and use of the API Lorcaserin. Lorcaserin is the drug substance of Belviq, an innovative weight-loss product that … Continue reading
Brazil: Overview of API registration
In Brazil, the health authority (ANVISA) will require that all Active Pharmaceutical Ingredients (APIs) manufactured in Brazil, imported for manufacturing of drug products, or included in imported finished products, are registered with the agency. This regulation has been put in … Continue reading
Posted in Brazil Tagged Active Pharmaceutical Ingredients, anvisa, API, brazil, import, Latin America, manufacturing, registration 8 Comments